Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider 2024-03-25 09:51
Mabwell Presented IDDC™ Platform Technology and ADC Drug Development Achievements at the 14th World ADC London 2024-03-21 14:11
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential 2024-03-19 22:00
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate 2024-03-19 21:02
Seegene and Springer Nature Announce Awardees for the Open Innovation Program 2024-03-15 13:41
European Wellness and Sabah Government to Propel State into World-Class Medical Wellness Tourism Biotech Hub 2024-03-14 18:46
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile 2024-03-14 06:00
Datasea to Drive Growth in its Acoustic Business via Product Upgrades and U.S. Market Entry 2024-03-12 22:40
Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting 2024-03-12 22:00
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications 2024-03-12 20:30
Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London 2024-03-11 22:00
Mabwell to Present the Clinical Data of 9MW2821 in Cervical Cancer as Focused Plenary Oral Presentation at 2024 Society of Gynecologic Oncology Annual Meeting on Women's Cancer 2024-03-08 22:00
Datasea Expects Approximately 1,128% Revenue Growth in 2024 2024-03-05 23:45
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
FDA Grants Fast Track Designation to 9MW2821 2024-02-27 22:00
Zhongchao Inc. Announces 1-for-10 Share Consolidation 2024-02-27 21:00
Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology 2024-02-21 22:00
Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year 2024-02-21 18:00
1 2 3 4 5 225